Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: July 11, 2016
Event: Receipt of a request for additional information from the U.S. Federal Trade Commission (FTC) regarding the proposed acquisition of St. Jude Medical Inc.
Key Financial Metrics
This filing is a current report regarding a regulatory event and does not contain financial statements. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the extension of the waiting period for the proposed acquisition of St. Jude Medical under the Hart-Scott Rodino Antitrust Improvements Act (HSR Act). The waiting period is extended until 30 days after Abbott and St. Jude Medical substantially comply with the FTC's request for additional information, unless terminated sooner by the FTC or extended voluntarily.
Guidance, Outlook, and Risks
- Transaction Status: The acquisition is not yet completed. There is no guarantee that the transaction will be completed or when it will be finalized.
- Forward-Looking Statements: Abbott cautions that expected benefits of the acquisition may not be realized due to economic, competitive, governmental, and technological risks.
- Regulatory Filings: A registration statement on Form S-4 (serving as a prospectus and proxy statement) has been filed but has not yet become effective.
- Shareholder Action: St. Jude Medical shareholders will receive a definitive proxy statement/prospectus following SEC effectiveness to vote on the transaction.
Investor Verification Checklist
- Monitor the status of the FTC's review and the compliance timeline for the HSR Act waiting period.
- Review the Form S-4 registration statement and proxy statement/prospectus once declared effective by the SEC for detailed transaction terms.
- Verify the outcome of the regulatory review to confirm if the acquisition proceeds or is terminated.
- Check for any voluntary extensions of the waiting period by the parties involved.